Healthcare >> CEO Interviews >> August 25, 2003
JOHN F. TALLMAN, PhD, is currently Chief Executive Officer and President
of Helicon Therapeutics, Inc. He was the Founder and Chief Scientific
Officer of Neurogen Corporation, a publicly traded NASDAQ company. In
that position, he led the advancement of a number of drugs to the clinic
with neuroscience indications. Dr. Tallman was also a member of the
neuroscience faculty at Yale University, and previously served as a
Section Chief at the National Institute of Mental Health. He is the
holder of numerous awards in neuroscience, and is the author of many
peer-reviewed papers in neuropharmacology. Profile
drug discovery and gene programs?
Mr. Tallman: Helicon Therapeutics is a privately held biotech company
that was
